Int J Gynecol Cancer. 2009 Oct;19(7):1156-9.

The counseling and management of young healthy BRCA mutation carriers.

Eitan R, Michaelson-Cohen R, Levavi H, Beller U.

Source

The Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, Israel. eitanr@clalit.org.il

Abstract

Although more than 15 years have elapsed since the discovery of the BRCA1 and BRCA2 genes and the associated increased risk of breast and ovarian cancers in mutation carriers, our understanding of the syndrome is still evolving. With the accumulation of knowledge, more questions arise regarding the proper approach to mutation carriers diagnosed as having cancer. Moreover, the number of questions regarding the recommended management methods for healthy carriers and the potential risk-reducing measures is increasing constantly.In this review, we discuss these issues and summarize contemporary recommendations.

PMID:: 19823049; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Related citations

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. [J Natl Cancer Inst. 2008]
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group. J Natl Cancer Inst. 2008 Nov 5; 100(21):1519-29. Epub 2008 Oct 28.
Review Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis. [Minerva Med. 2009]
Review Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
Quinn GP, Vadaparampil ST, Bower B, Friedman S, Keefe DL. Minerva Med. 2009 Oct; 100(5):371-83.
Review Management options after prophylactic surgeries in women with BRCA mutations: a review. [Cancer Control. 2007]
Review Management options after prophylactic surgeries in women with BRCA mutations: a review.
Allain DC, Sweet K, Agnese DM. Cancer Control. 2007 Oct; 14(4):330-7.
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. [Clin Cancer Res. 2008]
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, et al. Clin Cancer Res. 2008 May 1; 14(9):2861-9.
Review [Molecular basis of breast cancer related to BRCA 1 and BRCA2 genes: characteristics and targeting therapy]. [Lijec Vjesn. 2010]
Review [Molecular basis of breast cancer related to BRCA 1 and BRCA2 genes: characteristics and targeting therapy].
Levanat S, Cvok ML. Lijec Vjesn. 2010 Jan-Feb; 132(1-2):34-7.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

The counseling and management of young healthy BRCA mutation carriers.
The counseling and management of young healthy BRCA mutation carriers.
Int J Gynecol Cancer. 2009 Oct ;19(7):1156-9.

PubMed
Naproxen and celecoxib do not prevent AD in early results from a randomized cont...
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.
Neurology. 2007 May 22 ;68(21):1800-8. Epub 2007 Apr 25 .

PubMed
Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP...
Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe.
J Clin Pharmacol. 2001 Apr ;41(4):443-51.

PubMed
Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for th...
Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.
J Leukoc Biol. 2008 Jan ;83(1):31-8. Epub 2007 Oct 3 .

PubMed
Evidence for late stage compartmentalization of HIV-1 resistance mutations betwe...
Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells.
AIDS. 2000 Oct 20 ;14(15):2273-81.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

The counseling and management of young healthy BRCA mutation carriers.

Source

Abstract

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information